Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Amortizatization of Intangibles (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Amortizatization of Intangibles for 13 consecutive years, with $60000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 57.89% to $60000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $173000.0, a 14.57% increase, with the full-year FY2025 number at $173000.0, up 14.57% from a year prior.
  • Amortizatization of Intangibles was $60000.0 for Q4 2025 at Niagen Bioscience, up from $38000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $337000.0 in Q4 2021 to a low of -$362000.0 in Q4 2023.
  • A 5-year average of $58950.0 and a median of $46500.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 300.0% in 2023; the steepest drop was 941.86% in 2023.
  • Niagen Bioscience's Amortizatization of Intangibles stood at $337000.0 in 2021, then crashed by 87.24% to $43000.0 in 2022, then plummeted by 941.86% to -$362000.0 in 2023, then surged by 110.5% to $38000.0 in 2024, then skyrocketed by 57.89% to $60000.0 in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Amortizatization of Intangibles are $60000.0 (Q4 2025), $38000.0 (Q3 2025), and $38000.0 (Q2 2025).